Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking

Sandra Wiederkehr, PhD

Articles by Sandra Wiederkehr, PhD

Table 1-1.jpg

Interventional vs. Non-interventional Study Classification in the EU: Considerations on the Impact of Direct-to-Patient Contacts

ByJean Siebenaler, MD,Sandra Wiederkehr, PhD,Xavier Fournie, MD

October 14th 2016

A new clinical trial regulation in Europe aims to bring about harmonization of European Union (EU) clinical trial multi-country applications. This paper poses a consensual review, fine-tuning, and validation of study classification while further clarifications on this law are sought out.

Table 1-1-New-1481319911768.jpg

Considerations on the Impact of Direct-to-Patient Contacts

ByJean Siebenaler, MD,Sandra Wiederkehr, PhD,Xavier Fournie, MD

October 1st 2016

Applied Clinical Trials

Examining interventional vs. non-interventional clinical study classification in the EU.

Latest Updated Articles

Interventional vs. Non-interventional Study Classification in the EU: Considerations on the Impact of Direct-to-Patient Contacts
October 14th 2016
Considerations on the Impact of Direct-to-Patient Contacts
October 1st 2016

Trending on Applied Clinical Trials Online

Real-World Evidence Is Moving Upstream: Is the Data Infrastructure Ready?

The Data Inputs That Matter Most When Pressure-Testing a Protocol's Feasibility

ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval

Where AI Leads in Trial Design—and Where Humans Still Need To

ACT Brief: Trial Simulations and Protocol Risk, RBQM Financial Value Quantified, and Three Drug Approvals